ABBV logo

ABBV
Abbvie Inc

32,367
Mkt Cap
$400.69B
Volume
3.89M
52W High
$244.81
52W Low
$164.39
PE Ratio
93.97
ABBV Fundamentals
Price
$219.87
Prev Close
$222.44
Open
$221.70
50D MA
$223.75
Beta
0.33
Avg. Volume
7.3M
EPS (Annual)
$2.38
P/B
-148.80
Rev/Employee
$1.11M
$377,387.10
Loading...
Loading...
News
all
press releases
Stratos Wealth Partners LTD. Has $41.28 Million Stock Holdings in AbbVie Inc. $ABBV
Stratos Wealth Partners LTD. increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 6.2% in the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Cibc World Market Inc. Acquires 60,635 Shares of AbbVie Inc. $ABBV
Cibc World Market Inc. boosted its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 10.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The...
MarketBeat·9h ago
News Placeholder
Here's Why AbbVie (ABBV) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·1d ago
News Placeholder
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Zacks·1d ago
News Placeholder
Here's What Will Drive AbbVie's Top-line Growth in 2026
ABBV sees 2026 revenues rising to $67B as Rinvoq and Skyrizi drive growth, with neuroscience gains offsetting Humira erosion and oncology headwinds.
Zacks·1d ago
News Placeholder
Wealthfront Advisers LLC Has $40.61 Million Position in AbbVie Inc. $ABBV
Wealthfront Advisers LLC lifted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 9.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor...
MarketBeat·1d ago
News Placeholder
Promising Pharmaceutical Stocks To Watch Now - February 9th
Eli Lilly and Company, Novo Nordisk A/S, Pfizer, AbbVie, Abbott Laboratories, Gilead Sciences, and Bristol Myers Squibb are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...
MarketBeat·2d ago
News Placeholder
J&J Posts Innovative Medicine Growth in 2025 Amid Stelara Patent Loss
JNJ's Innovative Medicine unit grew sales 4.1% in 2025 despite Stelara'sZER LOE, topping $60B as Darzalex and new drugs offset pressure
Zacks·2d ago
News Placeholder
Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4?
PFE beat Q4 estimates, but weak COVID sales and soft 2026 guidance kept shares muted as investors weigh pipeline strength against looming headwinds.
Zacks·2d ago
News Placeholder
ProShare Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV
ProShare Advisors LLC trimmed its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 2.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC...
MarketBeat·2d ago
<
1
2
...
>

Latest ABBV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.